Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- AdvaMed® Congratulates Dr. Makary on his Confirmation as FDA Commissioner
- 3/27/2025 10:12:29 AM
- AdvaMed®, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Dr. Marty Makary to serve as commissioner of the U.S.
- Using LLMs to better understand autism diagnosis
- 3/26/2025 3:35:41 PM
- Most autism diagnoses are based on human intuition: medical professionals evaluate patients according to a specific set of criteria and provide their assessment.
- L’Oréal Announces Strategic Research Partnership with Tru Diagnostic to Advance Beauty and Longevity Science, through unlocking discoveries in Epigenomics.
- 3/26/2025 3:39:56 AM
- L’Oréal, the leader in the beauty industry, is thrilled to announce a strategic research and development partnership with Tru Diagnostic, the foremost authority in epigenomics(1) testing.
- Oxygen for Mars
- 3/25/2025 9:18:55 AM
- To mitigate global climate change, emissions of the primary culprit, carbon dioxide, must be drastically reduced. A newly developed process helps solve this problem: CO2 is directly split electrochemically into carbon and oxygen.
- Study Identifies Novel Pathway with Potential to Slow the Progression of Pulmonary Fibrosis
- 3/25/2025 9:17:06 AM
- Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor that senses mechanical forces in tissues including stress, strain, and stiffness.
- OA Publisher Waiving APC for Researchers Due to Funding Cuts
- 3/25/2025 8:00:00 AM
- Partners in Digital Health recognizes the challenges researchers are facing due to recent funding cuts to NGOs and universities. To support the continuation of amplifying groundbreaking work in digital health, blockchain, AI, and emerging tech innovations for healthcare and life sciences, Partners in Digital Heath (PDH) is waiving the Article Processing Charge (APC) for ONE …
- $38 Billion U.S. Commercial Weight Loss Market Pivots To Survive GLP-1 Drugs Explosion
- 3/25/2025 6:00:00 AM
- March 24, 2025 - Marketdata LLC, a leading market research firm tracking the weight loss market since 1989, has just released a new report: “The U.S.
- Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
- 3/25/2025 4:36:59 AM
- Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ FDA approval for AUCATZYL®, a recently approved CAR T therapy.
- Johnson & Johnson to break ground on new state-of-the-art biologics facility in North Carolina to deliver market-leading portfolio of transformational therapies
- 3/24/2025 10:20:27 AM
- • New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases • Delivering on Company’s plans for increased U.S.
- AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing
- 3/24/2025 10:01:32 AM
- AstraZeneca announced an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre together with major research and manufacturing agreements that will further advance life sciences in China.
- Telehealth and Medicine Today and International Society for Telemedicine and eHealth Announce Strategic Collaboration to Advance Global Digital Health Innovation
- 3/24/2025 8:00:00 AM
- Telehealth and Medicine Today (THMT) and the International Society for Telemedicine and eHealth (ISfTeH) are pleased to announce a strategic collaboration aimed at accelerating the global education and adoption of digital health, telemedicine, and eHealth solutions.
- Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
- 3/21/2025 9:57:52 AM
- Novartis receives third FDA approval for oral Fabhalta ® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) • Phase III study showed sustained proteinuria reduction at one year with favorable safety 1 • Fabhalta is the only oral alternative complement pathway inhibitor thought to target the underlying cause of C3G 1-3 • …
- AstraZeneca enters license agreement with Alteogen for subcutaneous formulations of multiple oncology assets
- 3/20/2025 10:50:32 AM
- AstraZeneca and Alteogen Inc. have entered into an exclusive license agreement for ALT-B4, a novel hyaluronidase utilising Hybrozyme™ platform technology.
- Congress abandons Medicare patients and their physicians
- 3/12/2025 10:32:29 AM
- The following statement is attributable to: Bruce A. Scott, M.D. President, American Medical Association “Physicians across the country are outraged that Congress’s proposed spending package locks in a devastating fifth consecutive year of Medicare cuts, threatening access to care for 66 million Medicare patients.
- Kenvue to Showcase New Clinical Data on Skin Longevity, Hydration and Sun Protection at American Academy of Dermatology Association Meeting
- 3/8/2025 2:04:37 PM
- Kenvue Inc. (NYSE: KVUE) will share new clinical data demonstrating how its iconic brands are leveraging the latest science to shape the future of the Skin Health & Beauty category at the 2025 American Academy of Dermatology (AAD) Annual Meeting, set for March 7-11, 2025 at the Orlando Convention Center in Orlando, Florida.
- Sudan: Attack leads to deadly wave of cholera in White Nile
- 3/7/2025 10:11:55 AM
- Since the start of the latest cholera outbreak in Sudan ’s White Nile State on February 20, more than 2,700 patients have been admitted to the Ministry of Health’s cholera treatment center at Kosti Teaching Hospital, supported by Doctors Without Borders/Médecins Sans Frontières (MSF).
- Dr. Rajendra Mannava’s Extensive and Organized Guide to Common Med Board Test Cases Set for Exhibit at L.A. Times Festival of Books
- 3/6/2025 1:37:39 PM
- Celebrity guest authors and panels will abound in the upcoming Los Angeles Times Festival of Books 2025, but it is also a big draw for the country’s hundreds of independent and self-published authors.
- AMA urges public to get vaccinated amid growing measles outbreaks 2025
- 3/6/2025 10:38:09 AM
- As the number of measles cases reported across the U.S. continues to grow, vaccination rates decline, and spring break travel begins, the American Medical Association (AMA) today issued the following statement urging individuals to get vaccinated against the measles if not already immune. The following statement is attributable to: Bruce A.
- AdvaMed Unveils “The Medical Innovation Agenda for the 119th Congress”
- 3/6/2025 10:36:02 AM
- AdvaMed, the Medtech Association, the largest global trade organization representing medical technology companies, released its “Medical Innovation Agenda for the 119th Congress.” These policy priorities would advance AdvaMed’s goal to usher in a new era of health care innovation on behalf of all American patients, promoting access to the latest lifesaving technologies. …
- Building a healthier world by women and for women is key to achieving gender equality
- 3/6/2025 10:34:20 AM
- As the world marks the 30th anniversary of the Beijing Declaration and Platform for Action on Women – a landmark blueprint for gender equality – progress remains frustratingly slow.